These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23001710)

  • 21. The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI.
    Harrington KD; Lim YY; Ellis KA; Copolov C; Darby D; Weinborn M; Ames D; Martins RN; Savage G; Szoeke C; Rowe C; Villemagne VL; Masters CL; Maruff P
    Int Psychogeriatr; 2013 Oct; 25(10):1667-77. PubMed ID: 23866942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).
    Lim YY; Jaeger J; Harrington K; Ashwood T; Ellis KA; Stöffler A; Szoeke C; Lachovitzki R; Martins RN; Villemagne VL; Bush A; Masters CL; Rowe CC; Ames D; Darby D; Maruff P
    Arch Clin Neuropsychol; 2013 Jun; 28(4):320-30. PubMed ID: 23552802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals.
    Sperling RA; Johnson KA; Doraiswamy PM; Reiman EM; Fleisher AS; Sabbagh MN; Sadowsky CH; Carpenter A; Davis MD; Lu M; Flitter M; Joshi AD; Clark CM; Grundman M; Mintun MA; Skovronsky DM; Pontecorvo MJ;
    Neurobiol Aging; 2013 Mar; 34(3):822-31. PubMed ID: 22878163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study.
    Pietrzak RH; Scott JC; Neumeister A; Lim YY; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    Br J Psychiatry; 2014; 204():400-1. PubMed ID: 24526746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageing.
    Pietrzak RH; Lim YY; Ames D; Harrington K; Restrepo C; Martins RN; Rembach A; Laws SM; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    Neurobiol Aging; 2015 Mar; 36(3):1231-8. PubMed ID: 25585532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased meta-memory is associated with early tauopathy in cognitively unimpaired older adults.
    Vannini P; d'Oleire Uquillas F; Jacobs HIL; Sepulcre J; Gatchel J; Amariglio RE; Hanseeuw B; Papp KV; Hedden T; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA
    Neuroimage Clin; 2019; 24():102097. PubMed ID: 31795044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β-Amyloid binding in elderly subjects with declining or stable episodic memory function measured with PET and [¹¹C]AZD2184.
    Mattsson P; Forsberg A; Persson J; Nyberg L; Nilsson LG; Halldin C; Farde L
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1507-11. PubMed ID: 26115835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraindividual cognitive decline using a brief computerized cognitive screening test.
    Darby DG; Pietrzak RH; Fredrickson J; Woodward M; Moore L; Fredrickson A; Sach J; Maruff P
    Alzheimers Dement; 2012; 8(2):95-104. PubMed ID: 22404851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autobiographical narratives relate to Alzheimer's disease biomarkers in older adults.
    Buckley RF; Saling MM; Irish M; Ames D; Rowe CC; Villemagne VL; Lautenschlager NT; Maruff P; Macaulay SL; Martins RN; Szoeke C; Masters CL; Rainey-Smith SR; Rembach A; Savage G; Ellis KA;
    Int Psychogeriatr; 2014 Oct; 26(10):1737-46. PubMed ID: 24969443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Episodic memory decline predicts cortical amyloid status in community-dwelling older adults.
    Darby DG; Brodtmann A; Pietrzak RH; Fredrickson J; Woodward M; Villemagne VL; Fredrickson A; Maruff P; Rowe C
    J Alzheimers Dis; 2011; 27(3):627-37. PubMed ID: 21876253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease.
    Chételat G; Villemagne VL; Pike KE; Ellis KA; Ames D; Masters CL; Rowe CC;
    Neurodegener Dis; 2012; 10(1-4):141-4. PubMed ID: 22301812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation.
    Mander BA; Marks SM; Vogel JW; Rao V; Lu B; Saletin JM; Ancoli-Israel S; Jagust WJ; Walker MP
    Nat Neurosci; 2015 Jul; 18(7):1051-7. PubMed ID: 26030850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
    Villemagne VL; Burnham S; Bourgeat P; Brown B; Ellis KA; Salvado O; Szoeke C; Macaulay SL; Martins R; Maruff P; Ames D; Rowe CC; Masters CL;
    Lancet Neurol; 2013 Apr; 12(4):357-67. PubMed ID: 23477989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
    Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.
    Villemagne VL; Pike KE; Darby D; Maruff P; Savage G; Ng S; Ackermann U; Cowie TF; Currie J; Chan SG; Jones G; Tochon-Danguy H; O'Keefe G; Masters CL; Rowe CC
    Neuropsychologia; 2008; 46(6):1688-97. PubMed ID: 18343463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low amyloid-β deposition correlates with high education in cognitively normal older adults: a pilot study.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Kosaka J; Kudo T; Iida H; Kishimoto T
    Int J Geriatr Psychiatry; 2015 Sep; 30(9):919-26. PubMed ID: 25425062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-Amyloid is associated with reduced cognitive function in healthy older adults.
    Gunstad J; Spitznagel MB; Glickman E; Alexander T; Juvancic-Heltzel J; Walter K; Murray L
    J Neuropsychiatry Clin Neurosci; 2008; 20(3):327-30. PubMed ID: 18806236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.
    Rembach A; Faux NG; Watt AD; Pertile KK; Rumble RL; Trounson BO; Fowler CJ; Roberts BR; Perez KA; Li QX; Laws SM; Taddei K; Rainey-Smith S; Robertson JS; Vandijck M; Vanderstichele H; Barnham KJ; Ellis KA; Szoeke C; Macaulay L; Rowe CC; Villemagne VL; Ames D; Martins RN; Bush AI; Masters CL;
    Alzheimers Dement; 2014 Jan; 10(1):53-61. PubMed ID: 23491263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.